340 related articles for article (PubMed ID: 33046515)
21. Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3.
Trovato R; Fiore A; Sartori S; Canè S; Giugno R; Cascione L; Paiella S; Salvia R; De Sanctis F; Poffe O; Anselmi C; Hofer F; Sartoris S; Piro G; Carbone C; Corbo V; Lawlor R; Solito S; Pinton L; Mandruzzato S; Bassi C; Scarpa A; Bronte V; Ugel S
J Immunother Cancer; 2019 Sep; 7(1):255. PubMed ID: 31533831
[TBL] [Abstract][Full Text] [Related]
22. Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer.
Yamamoto K; Tateishi K; Kudo Y; Hoshikawa M; Tanaka M; Nakatsuka T; Fujiwara H; Miyabayashi K; Takahashi R; Tanaka Y; Ijichi H; Nakai Y; Isayama H; Morishita Y; Aoki T; Sakamoto Y; Hasegawa K; Kokudo N; Fukayama M; Koike K
Oncotarget; 2016 Sep; 7(38):61469-61484. PubMed ID: 27528027
[TBL] [Abstract][Full Text] [Related]
23. Distinct Stromal and Immune Features Collectively Contribute to Long-Term Survival in Pancreatic Cancer.
Sadozai H; Acharjee A; Eppenberger-Castori S; Gloor B; Gruber T; Schenk M; Karamitopoulou E
Front Immunol; 2021; 12():643529. PubMed ID: 33679807
[No Abstract] [Full Text] [Related]
24. An increased abundance of tumor-infiltrating regulatory T cells is correlated with the progression and prognosis of pancreatic ductal adenocarcinoma.
Tang Y; Xu X; Guo S; Zhang C; Tang Y; Tian Y; Ni B; Lu B; Wang H
PLoS One; 2014; 9(3):e91551. PubMed ID: 24637664
[TBL] [Abstract][Full Text] [Related]
25. The activated stroma index is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma.
Erkan M; Michalski CW; Rieder S; Reiser-Erkan C; Abiatari I; Kolb A; Giese NA; Esposito I; Friess H; Kleeff J
Clin Gastroenterol Hepatol; 2008 Oct; 6(10):1155-61. PubMed ID: 18639493
[TBL] [Abstract][Full Text] [Related]
26. Autophagy loss impedes cancer-associated fibroblast activation via downregulating proline biosynthesis.
Bai J; Liu T; Tu B; Yuan M; Shu Z; Fan M; Huo S; Guo Y; Wang L; Wang H; Zhao Y
Autophagy; 2023 Feb; 19(2):632-643. PubMed ID: 35786294
[TBL] [Abstract][Full Text] [Related]
27. Fibroblasts in urothelial bladder cancer define stroma phenotypes that are associated with clinical outcome.
Mezheyeuski A; Segersten U; Leiss LW; Malmström PU; Hatina J; Östman A; Strell C
Sci Rep; 2020 Jan; 10(1):281. PubMed ID: 31937798
[TBL] [Abstract][Full Text] [Related]
28. Expression of classical human leukocyte antigen class I antigens, HLA-E and HLA-G, is adversely prognostic in pancreatic cancer patients.
Hiraoka N; Ino Y; Hori S; Yamazaki-Itoh R; Naito C; Shimasaki M; Esaki M; Nara S; Kishi Y; Shimada K; Nakamura N; Torigoe T; Heike Y
Cancer Sci; 2020 Aug; 111(8):3057-3070. PubMed ID: 32495519
[TBL] [Abstract][Full Text] [Related]
29. Fibroblast Activation Protein-Targeted Photodynamic Therapy of Cancer-Associated Fibroblasts in Murine Models for Pancreatic Ductal Adenocarcinoma.
Dorst DN; Smeets EMM; Klein C; Frielink C; Geijs D; Trajkovic-Arsic M; Cheung PFY; Stommel MWJ; Gotthardt M; Siveke JT; Aarntzen EHJG; van Lith SAM
Mol Pharm; 2023 Aug; 20(8):4319-4330. PubMed ID: 37485886
[TBL] [Abstract][Full Text] [Related]
30. Periostin- and podoplanin-positive cancer-associated fibroblast subtypes cooperate to shape the inflamed tumor microenvironment in aggressive pancreatic adenocarcinoma.
Neuzillet C; Nicolle R; Raffenne J; Tijeras-Raballand A; Brunel A; Astorgues-Xerri L; Vacher S; Arbateraz F; Fanjul M; Hilmi M; Samain R; Klein C; Perraud A; Rebours V; Mathonnet M; Bièche I; Kocher H; Cros J; Bousquet C
J Pathol; 2022 Dec; 258(4):408-425. PubMed ID: 36102377
[TBL] [Abstract][Full Text] [Related]
31. Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma.
Helm O; Mennrich R; Petrick D; Goebel L; Freitag-Wolf S; Röder C; Kalthoff H; Röcken C; Sipos B; Kabelitz D; Schäfer H; Oberg HH; Wesch D; Sebens S
PLoS One; 2014; 9(5):e94357. PubMed ID: 24797069
[TBL] [Abstract][Full Text] [Related]
32. Identification of Functional Heterogeneity of Carcinoma-Associated Fibroblasts with Distinct IL6-Mediated Therapy Resistance in Pancreatic Cancer.
McAndrews KM; Chen Y; Darpolor JK; Zheng X; Yang S; Carstens JL; Li B; Wang H; Miyake T; Correa de Sampaio P; Kirtley ML; Natale M; Wu CC; Sugimoto H; LeBleu VS; Kalluri R
Cancer Discov; 2022 Jun; 12(6):1580-1597. PubMed ID: 35348629
[TBL] [Abstract][Full Text] [Related]
33. Cellular collusion: cracking the code of immunosuppression and chemo resistance in PDAC.
Musiu C; Lupo F; Agostini A; Lionetto G; Bevere M; Paiella S; Carbone C; Corbo V; Ugel S; De Sanctis F
Front Immunol; 2024; 15():1341079. PubMed ID: 38817612
[TBL] [Abstract][Full Text] [Related]
34. Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer.
Feig C; Jones JO; Kraman M; Wells RJ; Deonarine A; Chan DS; Connell CM; Roberts EW; Zhao Q; Caballero OL; Teichmann SA; Janowitz T; Jodrell DI; Tuveson DA; Fearon DT
Proc Natl Acad Sci U S A; 2013 Dec; 110(50):20212-7. PubMed ID: 24277834
[TBL] [Abstract][Full Text] [Related]
35. Keratin 17 modulates the immune topography of pancreatic cancer.
Delgado-Coka L; Horowitz M; Torrente-Goncalves M; Roa-Peña L; Leiton CV; Hasan M; Babu S; Fassler D; Oentoro J; Bai JK; Petricoin EF; Matrisian LM; Blais EM; Marchenko N; Allard FD; Jiang W; Larson B; Hendifar A; Chen C; Abousamra S; Samaras D; Kurc T; Saltz J; Escobar-Hoyos LF; Shroyer KR
J Transl Med; 2024 May; 22(1):443. PubMed ID: 38730319
[TBL] [Abstract][Full Text] [Related]
36. Blockade of fibroblast activation protein in combination with radiation treatment in murine models of pancreatic adenocarcinoma.
Gunderson AJ; Yamazaki T; McCarty K; Phillips M; Alice A; Bambina S; Zebertavage L; Friedman D; Cottam B; Newell P; Gough MJ; Crittenden MR; Van der Veken P; Young KH
PLoS One; 2019; 14(2):e0211117. PubMed ID: 30726287
[TBL] [Abstract][Full Text] [Related]
37. Fibroblast activation protein-targeted near-infrared photoimmunotherapy depletes immunosuppressive cancer-associated fibroblasts and remodels local tumor immunity.
Akai M; Noma K; Kato T; Nishimura S; Matsumoto H; Kawasaki K; Kunitomo T; Kobayashi T; Nishiwaki N; Kashima H; Kikuchi S; Ohara T; Tazawa H; Choyke PL; Kobayashi H; Fujiwara T
Br J Cancer; 2024 Jun; 130(10):1647-1658. PubMed ID: 38555315
[TBL] [Abstract][Full Text] [Related]
38. Characterization of spatial distribution of tumor-infiltrating CD8
Masugi Y; Abe T; Ueno A; Fujii-Nishimura Y; Ojima H; Endo Y; Fujita Y; Kitago M; Shinoda M; Kitagawa Y; Sakamoto M
Mod Pathol; 2019 Oct; 32(10):1495-1507. PubMed ID: 31186528
[TBL] [Abstract][Full Text] [Related]
39. Adipose tissue-derived stromal cells are sources of cancer-associated fibroblasts and enhance tumor progression by dense collagen matrix.
Okumura T; Ohuchida K; Kibe S; Iwamoto C; Ando Y; Takesue S; Nakayama H; Abe T; Endo S; Koikawa K; Sada M; Horioka K; Mochidome N; Arita M; Moriyama T; Nakata K; Miyasaka Y; Ohtsuka T; Mizumoto K; Oda Y; Hashizume M; Nakamura M
Int J Cancer; 2019 Mar; 144(6):1401-1413. PubMed ID: 30152542
[TBL] [Abstract][Full Text] [Related]
40. Neutrophil extracellular traps promote liver micrometastasis in pancreatic ductal adenocarcinoma via the activation of cancer‑associated fibroblasts.
Takesue S; Ohuchida K; Shinkawa T; Otsubo Y; Matsumoto S; Sagara A; Yonenaga A; Ando Y; Kibe S; Nakayama H; Iwamoto C; Shindo K; Moriyama T; Nakata K; Miyasaka Y; Ohtsuka T; Toma H; Tominaga Y; Mizumoto K; Hashizume M; Nakamura M
Int J Oncol; 2020 Feb; 56(2):596-605. PubMed ID: 31894273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
